Personalized Immunotherapy in Patients With Recurrent /Metastatic SCCHN That Have Progressed on Prior Immunotherapy
University of Pittsburgh
University of Pittsburgh
Columbia University
Leap Therapeutics, Inc.
Bristol-Myers Squibb
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
SQZ Biotechnologies
AIO-Studien-gGmbH
Bristol-Myers Squibb
UNICANCER
Bristol-Myers Squibb